Revelation Biosciences effects 1-for-16 reverse stock split; shares outstanding cut to ~522K

REVELATION BIOSCIENCES, INC.

Reverse stock split effective Jan 28, 2025, at 1-for-16 ratio; no fractional shares issued.
Approximately 522,281 shares of common stock outstanding after the split.
Proportionate adjustments made to all outstanding equity awards and warrants, except certain warrants with price reset features.
Common stock continues to trade under symbol REVB on Nasdaq; new CUSIP 76135L606.
Split approved by stockholders at Jan 17, 2025 special meeting.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

REVELATION BIOSCIENCES, INC.: Certificate of Amendment to Third Amended and Restated Certificate of Incorporation filed to effect a 1-for-16 reverse stock split (effective 2025-01-28).

Change: charter amendment
Effective: 2025-01-28

Exact text from the filing

the Company filed a Certificate of Amendment to the Third Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”) effective on January 28, 2025, which effected a 1-for-16 reverse stock split as of 12:01 a.m. Eastern Standard Time on January 28, 2025

View on SEC.gov

83 governance changes filed in the last 30 days. Browse all governance changes →

REVELATION BIOSCIENCES, INC. filing history →

Source: SEC EDGAR

accession 0000950170-25-011197

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.